Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Exsymol
Monaco, Monaco, Monacoexsymol.com ↗
- Ownership
- Private
- Employees
- ~50
- Development stage
- Other
01
Overview
Exsymol’s cosmetic actives have demonstrated efficacy in anti-aging, skin hydration, and anti-glycation, supported by both clinical and in vitro data; their latest innovation, ADENOSILANE, won the BSB Innovation Award 2022 for anti-aging and pore tightening obtained via biotechnological fermentation[5].
- Therapeutic areas
- Metabolic DisordersDermatology
- Modalities
- Small moleculePeptidesOrganic silicon derivativesBotanical extractsBiomolecule derivatives
- Industry
- Non-Drug Biotech
02
Partnerships
35+ international distributorsPartnerships with major cosmetic brands (not public, but referenced as "the biggest cosmetic brands")
Beyond the preview
Go deeper on Exsymol.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Exsymol.